Catalyst Biosciences, Inc. (NASDAQ: CBIO), relating to the proposed purchase of F351, a chemical entity owned by GNI Group Ltd.
Catalyst Biosciences, Inc. (NASDAQ: CBIO), relating to the proposed purchase of F351, a chemical entity owned by GNI Group Ltd.